Background: Waitlist mortality remains a critical issue for pediatric heart transplant (HTx) candidates, particularly for candidates with congenital heart disease. Listing center organ offer acceptance practices have been identified as a factor influencing waitlist outcomes. We utilized machine learning (ML) to identify factors associated with waitlist mortality, combining variables associated with institutional offer acceptance practices as well as candidate‐specific risk factors. Methods: We analyzed the Organ Procurement and Transplantation Network database for pediatric HTx candidates listed between 2010 and 2020. Various statistical and ML models were employed to identify predictors of waitlist mortality or clinical deterioration leading to waitlist removal. The dataset was split into training (82%) and testing (18%), and the final model was selected based on predictive performance. SHAP values were used to assess variable importance. Results: Among 5523 pediatric candidates, overall waitlist mortality was 9.8%. The CatBoost model achieved the highest predictive performance with an AUC‐ROC score of 0.74 and a recall score of 0.75. Key predictors included candidate diagnosis, age/size, ventilator use, eGFR, serum albumin, ECMO, and institutional factors such as high offer refusal rates and low transplant volume. Conclusions: Institutional organ offer acceptance practices influence waitlist outcomes for pediatric HTx candidates. Centers with higher organ refusal rates are associated with worse outcomes, independent of candidate‐specific risk factors, underscoring the need for standardizing organ acceptance criteria across institutions to reduce variability in decision‐making and improve waitlist survival. Additionally, addressing modifiable risk factors such as malnutrition and renal dysfunction could further optimize patient outcomes.
Traditional methods to learn soft-tissue surgical procedures rely on cadaver labs or patient-based learning, which are costly and geographically limited, and raise ethical questions. Virtual reality (VR) with haptic feedback offers a scalable alternative, but most current platforms emphasize bone-based rather than soft-tissue procedures learned by feel. We developed a VR+haptic simulation for preoperative training of retropubic midurethral sling (MUS) surgery. This study examines the usability of this platform with thirteen expert urogynecologic surgeons and subsequently makes improvements (e.g., in haptics) to evaluate the platform with twelve trainees based on the NASA Task Load Index for workload and a UTAUT-informed usability survey. Objective performance scores were recorded as participants completed up to four levels of increasing realism and difficulty, starting with a transparent body and a reference surgical trajectory. Trainees reported high usability, immersion, and engagement. Experts rated the platform as valuable for sling training and skill assessment. NASA-TLX results indicated low physical and temporal demand, low mental demand and frustration, and moderate effort. These findings suggest that SurgicalEd VR is acceptable and has appropriate workload characteristics for surgical education. Future studies could examine how using VR+ haptic training improves intraoperative performance.
Purpose: Donation after circulatory death (DCD) is an emerging heart transplantation (HT) strategy with improved waitlist and comparable post‐transplant outcomes to donation after brain death (DBD) in adults. Pediatric DCD‐HT is underutilized but gaining broader adoption. We assessed the impact of DCD listing on waitlist outcomes and graft survival in pediatric HT. Methods: We queried the OPTN (Organ Procurement and Transplantation Network)/UNOS (United Network for Organ Sharing) database for all pediatric primary isolated HT candidates between January 2021 and June 2024. Waitlist outcomes were compared by final listing type to account for crossovers. Offer dynamics were assessed by average interval between offers stratified by OPTN/UNOS status. Multivariable regression modeled offer frequency as a function of DCD listing. We compared 30‐day survival between recipients of DCD and DBD organs. Results: Among 2486 candidates, 86 were initially listed eligible for DCD and 2400 for DBD. DCD candidates had higher clinical acuity than DBD candidates. DCD listing was associated with significantly shorter intervals between offers across all statuses and increased offer rate by 134% (95% CI: 92%–186%). Waitlist outcomes did not differ significantly by final listing type. There was no difference in 30‐day survival between DCD and DBD recipients. Conclusions: DCD listing in pediatric HT is associated with a shorter interval between offers and more frequent offers. Waitlist survival was similar between groups despite DCD candidates being sicker at listing. There was no difference in 30‐day survival between DCD and DBD recipients. These findings suggest that broader adoption of pediatric DCD‐HT can expand access to donor hearts without compromising early post‐transplant outcomes.